Hypertension and menopausal syndrome: effects of hormone replacement therapy and antihypertensive drugs.

A Amoroso, P Garzia, G M Ferri, C Clementia, T Battaglia, G Clemenzia
{"title":"Hypertension and menopausal syndrome: effects of hormone replacement therapy and antihypertensive drugs.","authors":"A Amoroso,&nbsp;P Garzia,&nbsp;G M Ferri,&nbsp;C Clementia,&nbsp;T Battaglia,&nbsp;G Clemenzia","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Arterial hypertension is a common finding in climacteric women even though the role of reduced estrogen levels in promoting this condition remains unclear. The purpose of the present survey was to evaluate the effects of hormone replacement therapy in hypertensive postmenopausal women. 180 patients were studied; they had been postmenopausal for 12-18 months and afflicted with mild or moderate essential arterial hypertension for less than 2 years. Patients were randomly divided into two groups and treated with progestin-estrogen therapy (group I, 96 patients) or with antihypertensive drugs (group II, 84 patients). Fourty-one cases in group I (42.7%) responded adequately to hormone therapy with persistent normalization of blood pressure levels; antihypertensive drugs were effective in 61 patients in group II (72.5%). The 23 unresponsive patients in group II were subsequently treated with progestin-estrogen therapy and a normalization of pressure values was achieved in 10 of these (43.5%). These results suggest that hormonal treatment determines, in at least one third of the cases, a significant reduction in blood pressure values. Moreover, hormone replacement may be effective even in patients that have not responded to antihypertensive drugs.</p>","PeriodicalId":21382,"journal":{"name":"Rivista europea per le scienze mediche e farmacologiche = European review for medical and pharmacological sciences = Revue europeenne pour les sciences medicales et pharmacologiques","volume":"18 4","pages":"149-52"},"PeriodicalIF":0.0000,"publicationDate":"1996-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Rivista europea per le scienze mediche e farmacologiche = European review for medical and pharmacological sciences = Revue europeenne pour les sciences medicales et pharmacologiques","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Arterial hypertension is a common finding in climacteric women even though the role of reduced estrogen levels in promoting this condition remains unclear. The purpose of the present survey was to evaluate the effects of hormone replacement therapy in hypertensive postmenopausal women. 180 patients were studied; they had been postmenopausal for 12-18 months and afflicted with mild or moderate essential arterial hypertension for less than 2 years. Patients were randomly divided into two groups and treated with progestin-estrogen therapy (group I, 96 patients) or with antihypertensive drugs (group II, 84 patients). Fourty-one cases in group I (42.7%) responded adequately to hormone therapy with persistent normalization of blood pressure levels; antihypertensive drugs were effective in 61 patients in group II (72.5%). The 23 unresponsive patients in group II were subsequently treated with progestin-estrogen therapy and a normalization of pressure values was achieved in 10 of these (43.5%). These results suggest that hormonal treatment determines, in at least one third of the cases, a significant reduction in blood pressure values. Moreover, hormone replacement may be effective even in patients that have not responded to antihypertensive drugs.

分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
高血压和更年期综合征:激素替代疗法和降压药的作用。
动脉高血压在更年期妇女中很常见,尽管雌激素水平降低在促进这种情况中的作用尚不清楚。本研究的目的是评价激素替代疗法对绝经后高血压妇女的影响。研究了180例患者;她们绝经后12-18个月,患有轻度或中度原发性高血压不到2年。患者随机分为两组,分别采用黄体酮-雌激素治疗组(I组,96例)和降压药治疗组(II组,84例)。I组41例(42.7%)对激素治疗有充分反应,血压水平持续正常化;II组降压药有效61例(72.5%)。II组23例无反应患者随后接受黄体酮-雌激素治疗,其中10例(43.5%)血压值恢复正常。这些结果表明,在至少三分之一的病例中,激素治疗决定了血压值的显著降低。此外,即使对降压药没有反应的患者,激素替代也可能有效。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
The mouth-stomach crossing of Helicobacter pylori. HCV and dermatomyositis: report of 5 cases of dermatomyositis in patients with HCV infection. Effective treatment of osteoarthritis with a 150 mg prolonged-release of diclofenac sodium. Toxoplasmosis in pregnancy: research on 2295 women in Rome and its province. Transcranial Doppler validation of hemodynamic vertebrobasilar insufficiency diagnosis.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1